Search the collection

3 results for Liu,+Mei-Ching,+MD

Sort by:

Sort by

Limit results to:

20 per page

3 results for Liu,+Mei-Ching,+MD

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Author / Creator:Tripathy, Debu, Prof ; Im, Seock-Ah, Prof ; Colleoni, Marco, MD ; Franke, Fabio, MD ; Bardia, Aditya, MBBS ; Harbeck, Nadia, Prof ; Hurvitz, Sara A, MD ; Chow, Louis, MBBS ; Sohn, Joohyuk, Prof ; Lee, Keun Seok, MD ; Campos-Gomez, Saul, Prof ; Villanueva Vazquez, Rafael, MD ; Jung, Kyung Hae, MD ; Babu, K Govind, Prof ; Wheatley-Price, Paul, MBChB ; De Laurentiis, Michelino, Prof ; Im, Young-Hyuck, Prof ; Kuemmel, Sherko, Prof ; El-Saghir, Nagi, Prof ; Liu, Mei-Ching, MD ; Carlson, Gary, BSc ; Hughes, Gareth, PhD ; Diaz-Padilla, Ivan, MD ; Germa, Caroline, MD ; Hirawat, Samit, MD ; Lu, Yen-Shen, MD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2018-07, Vol.19 (7), p.904-915
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 ra...
Author / Creator:Gianni, Luca, Prof ; Pienkowski, Tadeusz, Prof ; Im, Young-Hyuck, Prof ; Tseng, Ling-Ming, MD ; Liu, Mei-Ching, MD ; Lluch, Ana, MD ; Starosławska, Elżbieta, Prof ; de la Haba-Rodriguez, Juan, MD ; Im, Seock-Ah, Prof ; Pedrini, Jose Luiz, MD ; Poirier, Brigitte, MD ; Morandi, Paolo, MD ; Semiglazov, Vladimir, Prof ; Srimuninnimit, Vichien, Prof ; Bianchi, Giulia Valeria, MD ; Magazzù, Domenico, PhD ; McNally, Virginia, PhD ; Douthwaite, Hannah, MSc ; Ross, Graham, FFPM ; Valagussa, Pinuccia, BS
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2016-06, Vol.17 (6), p.791-800
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phas...
Author / Creator:Gianni, Luca, Dr ; Pienkowski, Tadeusz, Prof ; Im, Young-Hyuck, Prof ; Roman, Laslo, MD ; Tseng, Ling-Ming, MD ; Liu, Mei-Ching, MD ; Lluch, Ana, MD ; Staroslawska, Elżbieta, Prof ; de la Haba-Rodriguez, Juan, MD ; Im, Seock-Ah, Prof ; Pedrini, Jose Luiz, MD ; Poirier, Brigitte, MD ; Morandi, Paolo, MD ; Semiglazov, Vladimir, Prof ; Srimuninnimit, Vichien, Prof ; Bianchi, Giulia, MD ; Szado, Tania, PhD ; Ratnayake, Jayantha, BSc ; Ross, Graham, MD ; Valagussa, Pinuccia, BS
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2012, Vol.13 (1), p.25-32
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

Export this record

Export record to excel

5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 ra...

Export this record

Export record to excel

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phas...

Refine your search